130 related articles for article (PubMed ID: 31180538)
1. miR‑92a contributes to cell proliferation, apoptosis and doxorubicin chemosensitivity in gastric carcinoma cells.
Tao XC; Zhang XY; Sun SB; Wu DQ
Oncol Rep; 2019 Jul; 42(1):313-320. PubMed ID: 31180538
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of inhibitor of growth protein 2 inhibits cell invasion and enhances chemosensitivity to 5-FU in human gastric cancer cells.
Zhong J; Yang L; Liu N; Zheng J; Lin CY
Dig Dis Sci; 2013 Nov; 58(11):3189-97. PubMed ID: 23864195
[TBL] [Abstract][Full Text] [Related]
3. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
[TBL] [Abstract][Full Text] [Related]
4. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
6. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
Hu J; Fang Y; Cao Y; Qin R; Chen Q
Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
[TBL] [Abstract][Full Text] [Related]
7. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
Deng LM; Tan T; Zhang TY; Xiao XF; Gu H
Int J Oncol; 2019 Aug; 55(2):451-461. PubMed ID: 31268161
[TBL] [Abstract][Full Text] [Related]
8. BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.
Yang W; Zhao S; Wu B; Xu J; Wu Z; Guo J; Zeng R
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1279-1288. PubMed ID: 31549215
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2.
Wang P; Li Z; Liu H; Zhou D; Fu A; Zhang E
Biochem Biophys Res Commun; 2016 Oct; 479(1):91-6. PubMed ID: 27622325
[TBL] [Abstract][Full Text] [Related]
10. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.
Wang Y; Zhou X; Shan B; Han J; Wang F; Fan X; Lv Y; Chang L; Liu W
Mol Med Rep; 2015 Nov; 12(5):6491-500. PubMed ID: 26352175
[TBL] [Abstract][Full Text] [Related]
13. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.
Yu C; Chen DQ; Liu HX; Li WB; Lu JW; Feng JF
Biomed Pharmacother; 2019 Jan; 109():2327-2334. PubMed ID: 30551491
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
15. MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.
Zhao D; Zhang Y; Song L
Pathol Oncol Res; 2018 Jul; 24(3):483-488. PubMed ID: 28667493
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C.
Li G; Yang F; Gu S; Li Z; Xue M
Mol Med Rep; 2016 Jan; 13(1):572-8. PubMed ID: 26573417
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA 494 increases chemosensitivity to doxorubicin in gastric cancer cells by targeting phosphodiesterases 4D.
Peng QP; Du DB; Ming Q; Hu F; Wu ZB; Qiu S
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):62-66. PubMed ID: 30672438
[TBL] [Abstract][Full Text] [Related]
18. miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1.
Zhang Y; Qu X; Li C; Fan Y; Che X; Wang X; Cai Y; Hu X; Liu Y
Tumour Biol; 2015 Apr; 36(4):2277-85. PubMed ID: 25407491
[TBL] [Abstract][Full Text] [Related]
19. Nuclear ING2 expression is reduced in osteosarcoma.
Han XR; Bai XZ; Sun Y; Yang Y
Oncol Rep; 2014 Nov; 32(5):1967-72. PubMed ID: 25190103
[TBL] [Abstract][Full Text] [Related]
20. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
Shang C; Guo Y; Zhang J; Huang B
Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
